Budd-Chiari Syndrome — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — JAK2 V617F mutation testing
Budd-Chiari syndrome (hepatic vein thrombosis) has an underlying myeloproliferative neoplasm (especially polycythaemia vera or essential thrombocythaemia) in up to 40–50% of cases. JAK2 V617F mutation testing is the single most important investigation to identify occult MPN, which may present with Budd-Chiari as its first manifestation. Full thrombophilia screening is also indicated.
Reference: eTG – 2025 – Gastrointestinal; EASL – 2016 – Vascular Liver Disease Guidelines